Stock LABS MEDIPHARM LABS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company MediPharm Labs Corp.

Equities

LABS

CA58504D1006

Pharmaceuticals

Market Closed - Toronto S.E.
Other stock markets
 20:40:24 03/05/2024 BST 		5-day change 1st Jan Change
0.085 CAD +6.25% Intraday chart for MediPharm Labs Corp. +6.25% +30.77%
03-27 MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5% MT
03-27 MediPharm Labs Narrows Q4 Loss, Revenue Grows MT

Business Summary

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

Number of employees: 166

Sales per Business

CAD in Million2022Weight2023Weight Delta
Canadian Adult Use and Wellness
31.0 %
13 60.2 % 10 31.0 % -22.96%
Canadian Medical Cannabis - Other
29.9 %
- - 10 29.9 % -
International Medical Cannabis
29.2 %
5 22.9 % 10 29.2 % +90.34%
Canadian Medical Cannabis - Clinics
5.6 %
- - 2 5.6 % -
Pharmaceutical and Business to Business
4.2 %
4 16.8 % 1 4.2 % -62.52%

Sales per region

CAD in Million2022Weight2023Weight Delta
Canada
69.8 %
15 66.4 % 23 69.8 % +57.17%
Australia
16.3 %
3 11.8 % 5 16.3 % +106.63%
Germany
10.8 %
4 16.5 % 4 10.8 % -1.89%
Other
3.0 %
1 5.3 % 1 3.0 % -14.02%

Managers

Managers TitleAgeSince
David Pidduck CEO
 Chief Executive Officer - 19/04/22
Greg Hunter DFI
 Director of Finance/CFO - 07/02/21
Keith Strachan PSD
 President - 30/09/18
William Gordon CTO
 Chief Tech/Sci/R&D Officer - 31/10/16
Kirk Binns AUD
 Comptroller/Controller/Auditor - 05/02/19
Ahmed Shehata LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Michael Bumby BRD
 Director/Board Member 60 31/03/23
David Pidduck CEO
 Chief Executive Officer - 19/04/22
Shelley Martin BRD
 Director/Board Member - 21/06/20
Chris Halyk BRD
 Director/Board Member - 03/08/20
Keith Strachan PSD
 President - 30/09/18
Chris Taves CHM
 Chairman - 12/07/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 404,048,949 394,227,179 ( 97.57 %) 0 97.57 %

Shareholders

NameEquities%Valuation
David Pidduck
3.326 %
13,347,417 3.326 % 840 887 $
Keith Strachan
0.5110 %
2,050,552 0.5110 % 129 185 $
Chris Taves
0.2492 %
1,000,000 0.2492 % 63 000 $
Greg Hunter
0.2125 %
852,911 0.2125 % 53 733 $
Michael Bumby
0.0290 %
116,400 0.0290 % 7 333 $
Miriam McDonald
0.0253 %
101,537 0.0253 % 6 397 $
Chris Halyk
0.0214 %
86,000 0.0214 % 5 418 $
Shelley Potts
0.000000 %
0 0.000000 % - $

Company contact information

MediPharm Labs Corp.

151 John Street

L4N 2L1, Barrie

+705-719-7425

http://www.medipharmlabs.com
address MediPharm Labs Corp.(LABS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Ratings for MediPharm Labs Corp.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.085 CAD
Average target price
0.1 CAD
Spread / Average Target
+17.65%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
MEDIPHARM LABS CORP. Stock MediPharm Labs Corp.
+30.77% 25.11M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+39.33% 6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-18.38% 4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.17% 3.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+3.98% 3.15B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.41% 2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+48.74% 1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.82% 1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-1.24% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.96% 1.6B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. LABS Stock
  4. Company MediPharm Labs Corp.